Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Sterling

Showing results (41-50 of 330) with videos related to

Pageof 33
Sort By:
Lancet (London, England)|September 19, 2003
TuberculosisThomas R Frieden, Timothy R Sterling, Sonal S Munsiff, et al.
Journal of the National Medical Association|December 30, 2008
Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitorsShaheena Asad, Todd Hulgan, Stephen P Raffanti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2004
Prognostic factors for survival differ according to CD4+ cell count among HIV-infected injection drug users: pre-HAART and HAART erasNoya Galai, David Vlahov, Joseph C Bareta, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolatesBrandon Eilertson, Fernanda Maruri, Amondrea Blackman, et al.
Pharmacoepidemiology and Drug Safety|April 26, 2012
Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritisChristina T Fiske, Marie R Griffin, Ed Mitchel, et al.
AIDS (London, England)|September 30, 2015
The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapyJohn R Koethe, Heather Grome, Cathy A Jenkins, et al.
The Journal of Infection|July 13, 2013
Female sex and discontinuation of isoniazid due to adverse effects during the treatment of latent tuberculosisApril C Pettit, James Bethel, Yael Hirsch-Moverman, et al.
The Journal of Infectious Diseases|October 2, 2002
Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage diseaseTimothy R Sterling, Donald R Hoover, Jacquie Astemborski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2011
An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapyJohn R Koethe, Cathy A Jenkins, Bryan E Shepherd, et al.
AIDS Research and Human Retroviruses|October 18, 2012
Outcomes of second combination antiretroviral therapy regimens among HIV-infected persons in clinical care: a multicenter cohort studySonia Napravnik, Joseph J Eron, Timothy R Sterling, et al.
Pageof 33

Showing results (41-50 of 330) with videos related to

Sort By:
Pageof 33
Lancet (London, England)|September 19, 2003
TuberculosisThomas R Frieden, Timothy R Sterling, Sonal S Munsiff, et al.
Journal of the National Medical Association|December 30, 2008
Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitorsShaheena Asad, Todd Hulgan, Stephen P Raffanti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2004
Prognostic factors for survival differ according to CD4+ cell count among HIV-infected injection drug users: pre-HAART and HAART erasNoya Galai, David Vlahov, Joseph C Bareta, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolatesBrandon Eilertson, Fernanda Maruri, Amondrea Blackman, et al.
Pharmacoepidemiology and Drug Safety|April 26, 2012
Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritisChristina T Fiske, Marie R Griffin, Ed Mitchel, et al.
AIDS (London, England)|September 30, 2015
The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapyJohn R Koethe, Heather Grome, Cathy A Jenkins, et al.
The Journal of Infection|July 13, 2013
Female sex and discontinuation of isoniazid due to adverse effects during the treatment of latent tuberculosisApril C Pettit, James Bethel, Yael Hirsch-Moverman, et al.
The Journal of Infectious Diseases|October 2, 2002
Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage diseaseTimothy R Sterling, Donald R Hoover, Jacquie Astemborski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2011
An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapyJohn R Koethe, Cathy A Jenkins, Bryan E Shepherd, et al.
AIDS Research and Human Retroviruses|October 18, 2012
Outcomes of second combination antiretroviral therapy regimens among HIV-infected persons in clinical care: a multicenter cohort studySonia Napravnik, Joseph J Eron, Timothy R Sterling, et al.
Pageof 33